Nitric oxide (NO) is a widespread and multifunctional biological messenger molecule. It mediates vasodilation of blood vessels, host defence against infectious agents and tumors, and neurotransmission of the central and peripheral nervous systems. In the nervous system, NO is generated by three nitric oxide synthase (NOS) isoforms (neuronal, endothelial and immunologic NOS). Endothelial NOS and neuronal NOS are constitutively expressed and activated by elevated intracellular calcium, whereas immunologic NOS is inducible with new RNA and protein synthesis upon immune stimulation. Neuronal NOS can be transcriptionally induced under conditions such as neuronal development and injury. NO may play a role not only in physiologic neuronal functions such as neurotransmitter release, neural development, regeneration, synaptic plasticity and regulation of gene expression but also in a variety of neurological disorders in which excessive production of NO leads to neural injury.
Nitric oxide is probably the smallest and most versatile NO synthases isoforms and regulation of NO generation
bioactive molecule identified. Convergence of multidisciplinary efforts in the field of immunology, cardiovascular pharmacology, chemistry, toxicology and neu-NO is formed by the enzymatic conversion of the guanidino nitrogen of l-arginine by NO synthase (NOS). robiology led to the revolutionary novel concept of NO as an unorthodox messenger.
1-3 The discovery of NO Three NOS isoforms, neuronal NOS (nNOS; type I), immunologic NOS (iNOS; type II) and endothelial NOS as a messenger molecule in the nervous system 4 also revised conventional concepts of neurotransmitters.
(eNOS; type III) have been isolated and cloned [5] [6] [7] [8] ( Table 1 ). All three isoforms are expressed in the cen-NO is freely diffusible across membranes and is not stored in synaptic vesicles and released by exocytosis tral nervous system (CNS). NO can also be generated nonenzymatically by the direct reduction of nitrite to upon membrane depolarization. NO seems to be terminated primarily by reaction with its targets. Thus, NO under acidic and highly reduced conditions that may occur under ischemic conditions. 9-10 nNOS and control of NO synthesis, by NOS, is the primary way to regulate NO actions. Rapid progress is being made eNOS are calcium/calmodulin-dependent and under most conditions are constitutively expressed. However, in understanding the regulation of NOS activity and the cellular and molecular targets of NO under physiolrecent studies indicate that both enzymes can be induced (ie new protein synthesis) under conditions ogic and pathologic conditions. Some of the emerging roles of NO in the nervous system include regulation or of stress, injury and differentiation. 11 iNOS is calciumindependent and its expression is primarily regulated control of neuronal morphogenesis, short-term or longterm synaptic plasticity, regulation of gene expression at the level of transcription. Interestingly, in the absence of the substrate, l-arginine, nNOS is able to and modification of sexual and aggressive behavior. Deregulated formation of NO from all three NOS isoproduce superoxide anion (O 2 · − ) and hydrogen peroxide. 12, 13 Under conditions of reduced arginine conforms plays a role in neural injury in a host of neurological disorders.
centrations substantial amounts of superoxide may be generated by NOS. 14 NOS generation of O 2 · − and NO in arginine-depleted cells can lead to peroxynitritemediated cellular injury. ation by protein kinase A (PKA), protein kinase C tochemistry has localized nNOS to the Golgi apparatus, endoplasmic reticulum, spines, dendritic shafts and (PKC), cyclic GMP-dependent protein kinase (PKG) and calcium-calmodulin protein kinase (CAM-k). 16, 17 axon terminals. 24, 25 In addition, nNOS and the NMDAreceptor subunits are colocalized in nNOS neurons. 26 Calcineurin, a calcium-calmodulin dependent protein phosphatase, is able to dephosphorylate NOS and sub-
The presence of a PDZ domain (DHR domain or GLGF repeat) in nNOS 27 and its role in the membrane associsequently increase its catalytic activity. 18 The immunosuppressant and calcineurin inhibitor, FK506 ation of nNOS in skeletal muscle 28 may provide insight into regulation of nNOS. PDZ domain interactions may (Tacrolimus), protects cultured cortical neurons against glutamate neurotoxicity by maintaining the mediate binding of nNOS to synaptic junctions through interactions with postsynaptic density-95 protein phosphorylated, catalytically inactive state of nNOS. 18 NO formation is also tightly regulated by controlling (PSD-95) and PSD-93. 29 Skeletal muscle membrane from patients with Duschene Muscular Dystrophy the levels of various necessary cofactors within the cell. 19 Recent studies identified a novel protein, PIN, which lack dystrophin also lack nNOS. 28, 30 nNOS is also significantly reduced in the skeletal muscle from which interacts with and potently inhibits the activity of nNOS. 20 PIN destabilizes the nNOS dimer, a conformdx mice, which do not express full-length dystrophin. nNOS mRNA, protein and enzymatic activity are mation necessary for activity. The highly conserved sequence of PIN suggests it plays a role in regulating all markedly reduced in mdx mouse skeletal muscle, 31 suggesting a role of NO in maintaining integrity and numerous NO-related biological processes. Regulation of iNOS primarily occurs at the level of gene transcripfunctional regulation of skeletal muscle membranes. tion and analysis of the promoter region indicates that iNOS has a complex pattern of regulation. 21, 22 iNOS Biochemistry of NO expression is induced in response to cytokines, lipopolysaccharide (LPS) and a host of other agents. 19 In NO is considered a highly reactive free radical due to its short half-life (3-6 s) in comparison to traditional the nervous system, NO generated by nNOS in glial cells negatively regulates iNOS expression through neuronal messenger molecules. NO, once produced, does not persist in its native form for very long, in that inhibition of NFB. 23 NOS may also be regulated by changes in its intrait is either rapidly oxidized, reduced, or complexed to various biomolecules (Table 2 ). The biological outcome cellular localization. Electron microscopic immunohis- 33 In addition to the free radical form, there are oxidized and reduced forms, residues, and it can also oxidize lipids, proteins and DNA. Thus, peroxynitrite is thought to be a key NO + (nitrosonium ion) and NO − (nitroxide ion), respectively, of NO. All three oxidation states of NO mediator of NO-mediated cytotoxicity. Nitrosylation of many proteins appears to be a potenmay exist in the brain and, in part, may be responsible for some of the conflicting activities attributed to NO. tially important regulatory system accounting for some of NO's physiologic actions. Protein-associated targets The NO free radical (NO·) is probably the form that exists in solution and is thought to be most likely the of NO include heme, cysteine (Cys) and tyrosine (Tyr) residues. At physiological pH, Cys residues are form of NO that is produced on stimulation of NOS.
NO binds to the heme moiety of guanylyl cyclase to efficiently nitrosylated, while other reactions such as further oxidation of nitrosothiol to sulfonic acid and induce a conformational change which activates the enzyme and results in cGMP formation. NO increases nitration of Tyr occur at a much slower rate. 43 NO may physiologically modulate glutamatergic neuroprostaglandin production by activating another hemecontaining enzyme, cyclooxygenase. 34 NO reacts with transmission through nitrosylation of the NMDA receptor. 33 However, other studies suggest that NO inhibits non-heme iron particularly with iron sulfur clusters in numerous enzymes. Peroxynitrite, a reaction product NMDA-induced currents through an interaction with cations rather than through the redox modulatory site of NO and O 2 · − , rather than NO, may react with iron sulfur clusters. 35 These reactions readily occur after of the NMDA receptor channel. 44 NO reacts with an active site cysteine of glyceraldehyde-3-phosphate macrophage activation. However, in contrast with the reversible reaction of NO with heme, the reaction of dehydrogenase (GAPDH) resulting in the direct binding of NAD to cysteine and inhibition of GAPDH cata-NO with iron sulfur clusters results in the dissolution of the cluster. 36 Through these interactions NO may lytic activity and depression of glycolysis. 45, 46 NO also reacts with cysteine residue of hemoglobin in the lung inhibit oxidative respiration and cause cytotoxicity. In the presence of NO cytosolic aconitase functions as the forming an S-nitrosyl hemoglobin. 47 NO is released from S-nitrosyl hemoglobin during arterial-venous iron-responsive element binding protein; and in its absence it functions as a cytosolic aconitase. 37, 38 NO transit and appears to control blood pressure, which may facilitate efficient oxygen delivery to tissues. disrupts aconitase activity and exposes its RNA binding site permitting binding of the iron-responsive NO reversibly inhibits the growth of rat dorsal root ganglion neurites. 48 This may be due to inhibition by element binding protein to the iron-responsive element.
39 Production of NO, through stimulation of NO of thioester-linked long-chained fatty acylation of neuronal proteins probably through a direct modifi-NMDA receptors in rat brain slices, stimulates the RNA-binding function of the iron-responsive element cation of substrate cysteine thiols in the neuronal growth cone. The role of calcineurin and its inhibitor, binding protein while diminishing its aconitase activity. The iron-responsive element binding protein immunosuppressant FK506 in neurite outgrowth 49, 50 further implicates NO's participation in growth cone has a discreet neuronal localization, thus it may be an important molecular target for NO action in the brain. 39 dynamics since calcineurin enhances NOS activity by maintaining it in a dephosphorylated, catalytically ive postures by wild-type males nor do they elicit submissive postures in response to attack by another active state. 18 mouse. 63 These behaviors may be a selective consequence of the loss of nNOS, since nNOS null mice have NO-mediated neural function no detectable abnormalities in brain structure 53 and have normal synaptic plasticity in the hippocampus 64 Studies on the peripheral nervous system have provided the best evidence for a transmitter role of NO.
and cerebellum. 65 Furthermore, plasma testosterone levels, which could account for both aggression and NOS inhibitors selectively block non-adrenergic and non-cholinergic (NANC) mediated relaxation of the sexual behavior, do not differ between wild-type and nNOS null mice. 63 In newt, brain NOS activity gastrointestinal tract. 51 These data coupled with the selective localization of nNOS to the myenteric plexus increases transiently during males' courtship behavior, suggesting that NO's role in reproductive behavior may indicate that NO functions as the NANC neurotransmitter. 52 Studies of gastrointestinal function in be conserved throughout vertebrate evolution. 66 Long-term potentiation (LTP) in the hippocampus mice with targeted disruption of the nNOS gene 53 further support a role of nNOS in gastrointestinal funcand long-term depression (LTD) in the cerebellum are forms of synaptic plasticity that are thought to be tion. These mice have marked enlargement of the stomach and hypertrophy of the inner circular muscle layer.
involved with learning and memory. 67, 68 Induction of LTP in the CA1 region of hippocampal slices usually NO is thought to mediate relaxation of the pyloric sphincter in response to a food bolus. The grossly disrequires calcium influx through post-synaptic NMDA receptor channels and enhancement of glutamate tended stomach and hypertrophy of the inner circular muscle layer is felt to be a compensatory response due release by Schaeffer collaterals and is thought to require release of a retrograde messenger from postsynto the inability of the pyloric sphincter to properly relax in response to a food bolus. The pathology aptic CA1 pyramidal cells. Support for the role of NO as a retrograde messenger includes studies in hipporesembles hypertrophic pyloric stenosis, in which the lack of NO may play a role since a recent study shows campal neurons in which NO produces an increase in the frequency of spontaneous miniature excitatory an absence of NADPH diaphorase staining in the myenteric neurons in human male infants with pyloric post-synaptic potentials and observations that direct application of NO elicits LTP. Furthermore, NOS stenosis. 54 Furthermore, the nNOS gene is a susceptibility locus for the infantile pyloric stenosis. 55 In circuinhibitors interfere with the establishment of LTP as does hemoglobin which binds NO and some NOS lar smooth muscle of gastric fundus, NO acts as an inhibitory neurotransmitter that mediates the slow inhibitors block LTP when directly injected into CA1 pyramidal neurons. [69] [70] [71] [72] Intracellular application of an component of inhibitory junction potentials. 56 nNOS is highly expressed in the pelvic plexus in NO scavenger or use of a UV-sensitive NO donor also supports the contention that postsynaptically generaxonal processes including the cavernosal nerve and plexus. nNOS is also present in the adventitia of the ated NO acts directly on the postsynaptic neuron to produce LTP. 73 Similar evidence exists for a role of NO deep cavernosal arteries and sinusoids in the periphery of the corpus cavernosa. NO functions as the NANC in LTD. 74, 75 Genetic knockout of nNOS or eNOS failed to support NO's role in LTP. LTP in nNOS null or neurotransmitter that mediates penile erections. Penile erections elicited by electrical stimulation of the eNOS null mice appeared normal and is still blockable by NOS inhibition. 64, 76 The role of NO in LTP has been cavernous nerve are blocked by low doses of NOS inhibitors in intact rats and NOS inhibitors block clarified by Kandel and colleagues who recently generated double knockout mice lacking both nNOS and NANC-stimulated relaxation of isolated cavernosal strips.
57,58 nNOS null mice display hypertrophied urieNOS expression and found that hippocampal LTP in the stratum radiatum of CA1 was markedly reduced. 76 nary bladders and loss of neurally mediated relaxation of urethral and bladder muscle providing a model for These mutant mice showed normal LTP in the stratum oriens of hippocampal CA1. Thus, there is both NOidiopathic voiding disorder in humans. 59 Additionally NO may regulate both sympathetic and parasympadependent and NO-independent of LTP. eNOS may play a primary role in NO-mediated LTP in wild-type thetic outflow. 60 NO may play a role in modulating behavior. Inhimice as adenovirus-mediated disruption of eNOS activity in wild-type hippocampal slices eliminates bition of NOS attenuates alcohol consumption in alcohol-preferring rats and prevents the acquisition of tol-NO-dependent LTP. 77 In honeybee, inhibition of NOS impairs a specific form of memory formed by olfactory erance to the ataxic effects of alcohol.
61 NO may be involved in light phase shifts of circadian rhythm in conditioning carried out by multiple learning trials. 78 Thus, involvement of NO in learning and memory may that NOS inhibitors block light-induced resetting of behavioral rhythms. 62 Studies in nNOS null mice probe conserved throughout the animal kingdom. NO influences neurotransmitter release presumably vide further insight into the behavioral roles of NO. Male nNOS null mice exhibit inappropriate sexual through cGMP activation of cGMP-dependent protein kinases to augment the phosphorylation of synaptic behavior, mounting females indiscriminately regardless of whether the females are in estrus or not. Furvesicle proteins associated with neurotransmitter release. The role of NO production in NMDA receptorthermore, male mice when housed together, fight incessantly and do not respond to appropriate submissmediated neurotransmitter release is evident from the studies in which inhibitors of NOS block NMDA recephypertrophy and ectopic NOS expression in larvae has the opposite effects, implicating NO as an antiprolifertor-mediated neurotransmitter release from the cerebral cortex or striatal synaptosomes. 78, 80 NO is involved in ative signal during development. 90 The molecular mechanism for NO's role in neural development is not glutamate or norepinephrine-stimulation and GABAinhibition of hypothalamic luteinizing hormone-releasknown. One intriguing hypothesis is that activation of mitogen-activated protein kinase (MAPK) pathway by ing hormone (LHRH) release. 81 In synaptosomes neurotransmitter release evoked by stimulation of NMDA NO may be a key to how NO regulates neuronal growth, differentiation, survival and death (Figure 1) . 91, 92 Our receptors is blocked by NOS inhibitors whereas release by potassium depolarization is unaffected. Presumably, recent studies indicate that stimulation of NMDA receptor in cultured cortical neurons activates Ras-ERK potassium depolarizes all terminals so that the effects of NO are diminished due to the limited population of pathway via calcium-dependent activation of nNOS and NO generation. 93 NMDA-stimulated phosphoryl-NOS-containing terminals. The mechanism of how NO influences neurotransmitter release is unclear. Howation of cyclic AMP-response element binding protein (CREB), a downstream effector of ERK, is also NOever, NO may act on both calcium-sensitive and calcium-insensitive pools of synaptic vesicles. 82 NO's dependent. 92 Activation of Ras/ERK pathway by NO may be mediated by direct activation of Ras GTPase actions on neurotransmitter release could involve cyclic GMP activation of cyclic GMP-dependent protein activity presumably by nitrosylation of cysteine through a redox-sensitive interaction. 93, 94 Since calkinase to augment phosphorylation of synaptic vesicle proteins or through activation of cyclic GMP depencium-dependent activation of Ras-MAPK pathway is thought to be a major pathway of neural activitydent-cation channels. 83 Recent studies indicate that NO may facilitate vesicle docking/fusion events by promotdependent long-term changes in nervous system, 95 NO may be a key mediator linking activity to gene ing VAMP/SNAP-25/syntaxin 1a complex formation and by inhibiting n-sec1 binding to syntaxin 1a. 84 This expression and long-term plasticity. NO donors activate all three types of MAPK (ERK, JNK/SAPK, p38 effect of NO may be mediated by nitrosylation of sulfhydryl groups of protein(s) involved. Thus, there MAPK) with different extent and time courses in T cell leukemic cell lines. 91 ERK and JNK/p38 MAPK pathmay be multiple molecular targets of NO acting in concert to modulate neurosecretion.
ways are implicated in neuronal survival and death, respectively. 96 Since the MAPK signaling pathway NO may play a key role in nervous system morphogenesis and synaptic plasticity. nNOS is transiently expressed in the cerebral cortical plate neurons from embryonic day E15-E19 of rats. 85 These cells extend their processes through to the corpus striatum and thalamus. This intense labeling of the cortical plate neurons and their processes decreases rapidly and vanishes by the 15th postnatal day. Embryonic sensory ganglia are nNOS positive and this decreases to less than 1% of the cells at birth. Thus, the transient expression of NOS may reflect a role in developmental processes. Molecular maturation of adult spinal cord motor neurons may involve NO. 86 NO may also play a role in the development of proper patterns of connections in the retinotectal system as NOS expression peaks at the time when refinement of the initial pattern of connections is occurring. 87 Neurons of the developing olfactory epithelium during migration and the establishment of primary synapses in the olfactory bulb of rats express nNOS during embryonic development. 88 Olfactory nNOS expression rapidly declines after birth and is undetectable by postnatal day 7. In addition, nNOS expression is rapidly induced in the regenerating olfactory receptor neuron after bulbectomy and is particularly enriched in their outgrowing axons. Thus, NO may play a role in activity-dependent establishment of connections in both developing and regenerating olfactory neurons. During neuronal differentiation nitric oxide may trigger a switch to growth arrest during differentiation of neuronal cells; and thus, NOS serves as a growth arrest gene initiating the switch to cytostasis during differentiation. 89 In Droso- zling phenomenon, we developed an NO-resistant PC12 cell line and determined using sequential analysis of gene expression that MnSOD accounts for the NO in neurological disorders resistance to NO. We then showed that nNOS neurons in the cortex are enriched in manganese SOD (MnSOD) Deregulated excess generation of NO can initiate a neurotoxic cascade. 97 Excess glutamate acting via NMDA which may prevent the local formation of toxic peroxynitrite, rendering nNOS neurons resistant to NO's toxic receptors mediates cell death in focal cerebral ischemia. 98 Glutamate neurotoxicity may also play a actions. 115 Overexpression of MnSOD by recombinant adenovirus in cultured cortical neurons markedly part in neurodegenerative diseases such as Huntington's disease and Alzheimer's disease. 99 NMDA increased resistance to NMDA-mediated cell death. 115 Furthermore, antisense knockdown of MnSOD renders applied only for a short (5 min) period of time is able to elicit cell death in cortical cultures assessed 24 h only nNOS neurons more susceptible to NO and NMDA toxicity. Thus, MnSOD is the major protective later. This type of toxicity has been called 'delayed or rapidly triggered neurotoxicity' in which irreversible protein in nNOS neurons. Other putative protective factors may exist in nNOS neurons and may represent processes are set in motion by the 5-min application of NMDA. 100 This type of toxicity is exquisitely depenspecifically expressed gene products in these cells. NO presumably kills neurons via peroxynitrite.
116 dent upon calcium. Furthermore, calcium influx via NMDA receptors elicits more potent toxicity than other NO interacts with the O 2 · − to form the toxic radical peroxynitrite. This powerful oxidant is thought to mediate modes of calcium entry. This type of toxicity involves NO since treatment with NOS inhibitors, removal of lmost NO neurotoxicity. Peroxynitrite may further decompose to hydroxyl and nitrogen dioxide radicals arginine or reduced hemoglobin which scavenges NO, blocks this form of toxicity. 101 Further evidence of the in vivo 117 which are also highly reactive and biologically destructive. role of NO in NMDA neurotoxicity comes from the studies in nNOS null mice which are relatively resist-NOS inhibitors block ischemic damage following middle cerebral artery (MCA) ligation in several animal ant to NMDA neurotoxicity as well as combined oxygen and glucose deprivation. 102 Despite the critical evimodels. 118 The notion that neuronally derived NO plays a role in neural damage following stroke is supdence for a role of NO in glutamate neurotoxicity, others have failed to confirm that NO is necessary for ported by the studies in nNOS null mice. These mice have reduced infarct volumes compared to ageglutamate neurotoxicity. [103] [104] [105] These discrepancies may be due to the finding that NO may possess either matched wild-type controls following permanent middle cerebral artery occlusion. 119 Inhibition of eNOS neurodestructive and neuroprotective properties, depending on its oxidation-reduction status, with NO · may account for the deleterious effects of NOS inhibitors. MCA occlusion of eNOS null mice leads to larger being neurodestructive and NO + being neuroprotective. 33 Furthermore, recent studies indicate that the infarcts than in wild-type mice. 120 This effect is associated with reduction in cerebral blood flow in the conditions under which neurons are cultured can profoundly influence the expression of nNOS and subischemic penumbra region. The selective nNOS inhibitor, 7-nitroindazole, which has a minimal effect on cersequent involvement of NO in excitotoxicity. 106 The expression of nNOS in primary cultures at levels equiebral blood flow is neuroprotective in animal models of focal ischemia. 121 Furthermore, when the nNOS null valent to in vivo expression (1-2% of the neuronal population) is critical for the ability to observe NOmice are treated with the NOS inhibitor, nitro-l-arginine methyl-ester, there are adverse effects on cerebral mediated neurotoxicity. In primary cultures the expression of nNOS is dependent on both the method blood flow and stroke volume is increased. Conversely, when eNOS null mice are treated with NOS inhibitors of culture and the age of the cultures. 106, 107 Neurotrophins, despite their general role in attenuating excitoduring MCA occlusion, infarct volume is reduced. 122 Thus, neuronally derived NO plays an important role toxic neuronal injury, were recently shown to increase nNOS neurons in cortical culture grown on glial feeder in mediating neuronal cell death following focal ischemia and endothelial-derived NO plays an layers and render neurons more sensitive to NMDA. 106 This finding is consistent with a previous report by important protective role by regulating and maintaining proper cerebral blood flow. [121] [122] [123] In the late Choi and colleagues on the enhancement of excitotoxic neuronal injury by neurotrophins under certain constage of cerebral ischemia (Ͼ6 h), post-ischemic inflammation induces iNOS expression and sustained ditions. 108 However, when neurons are grown on a poly-ornithine matrix, neurotrophins failed to enhance generation of large amounts of NO leads to delayed neural injury. 124 Supporting this idea is the observation the expression of nNOS and are neuroprotective, consistent with the neuroprotective role of neurotrophins that iNOS null mice have smaller infarcts after cerebral ischemia. 125 in neurotoxicity studies in intact animals. 109, 110 nNOS neurons are resistant to a variety of toxic NO may mediate other forms of neurotoxicity. NOS inhibitors protect against CNS oxygen toxicity. 126 insults including NMDA neurotoxicity and neurode- 130 are markedly resistant to MPTP neurotoxicity. NO may also play a role in the and thus serve as NOS inhibitors. Both FK506 and cyclosporin A are neuroprotective against NMDApathogenesis of AIDS dementia. Both neuronally and immunologically derived NO may contribute to AIDS induced neurotoxicity in cortical cultures. 18 The physiologic relevance of this observation was recently condementia. The HIV coat protein, gp120, which is shed by the virus, kills neurons in primary cortical cultures, firmed by the report that FK506 is profoundly neuroprotective in a rat model of focal ischemia. 135 in part, via the activation of nNOS. 131 Additionally, the coat proteins gp160, gp120 and gp41 induce iNOS in Gangliosides, which are neuroprotective in a variety of animal models, may be neuroprotective through inhimicroglial and astrocyte cultures. 132, 133 The role of iNOS in AIDS dementia has been established by recent bition of NOS as gangliosides inhibit NOS activity, and the protective potency of gangliosides closely parallels studies which show that iNOS is markedly induced in patients with severe AIDS dementia. 134 their affinities for calmodulin and their potencies for inhibiting NOS. 136 Other compounds such as 7-nitroinSince NO may be involved in stroke and other neurodegenerative disorders, strategies are currently being dazole and ARL17477, relatively selective nNOS inhibitors, and lamotrigine, a voltage-sensitive sodium developed to find selective NOS inhibitors. NOS can be inhibited indirectly, thus providing alternative strachannel blocker, 137 also have therapeutic potential in NO-mediated neurotoxicity. 125, 137 tegies for protection against NO-mediated cell death. The immunosuppressants FK506 and cyclosporin A Understanding the neurotoxic mechanisms of NO requires uncovering how NO acts on numerous potenwhich bind small soluble receptor proteins, designated FK506-binding proteins and cyclophilins, respectively, tial targets to which it can initiate neurotoxic cascades (Figure 2 ). NO probably mediates most of its toxic inhibit NOS and are neuroprotective. 18, 135 Immunosuppressants interact with their respective binding proeffects through interactions with O 2 · − to form peroxy- 
